inflammation.htm

IP-1005 for Inflammation

Inflammation has been implicated as a main or contributing cause to a wide range of conditions, including arthritis, heart disease, inflammatory bowel disease, diabetes, and others. In these conditions, inflammation affects approximately 27 million people in the United States.

IP-1005 is a proprietary fixed combination drug, with DHEA as a primary active ingredient, that reduces inflammatory markers and may reduce CRP.


	Back to Products IP-1005 for Inflammation Inflammation has been implicated as a main or contributing cause to a wide range of conditions, including arthritis, heart disease, inflammatory bowel disease, diabetes, and others. In these conditions, inflammation affects approximately 27 million people in the United States. IP-1005 is a proprietary fixed combination drug, with DHEA as a primary active ingredient, that reduces inflammatory markers and may reduce CRP.